Focal therapy in prostate cancer: Rationale, results and perspectives - Abstract

Focal therapy is a novel treatment strategy in prostate cancer aiming to treat only the area of the gland harbouring clinically significant disease.

The overall objective is to maintain the oncological benefit of active treatment while minimising treatment-related morbidity. Leading centres are currently evaluating various minimally invasive technologies in a rigorous manner. Oncological and functional results in mid-term are encouraging with low rate of urinary incontinence and erectile dysfunction. However, the oncological outcome needs to be evaluated in the long-term in the light of the prolonged natural history of the disease.

Written by:
Valerio M, Benamran D, Tawadros T, Cerantola Y, Meuwly JY, Lutchmaya-Flick C, Lhermitte B, Wirth G, Iselin C, Jichlinski P.   Are you the author?

Reference: Rev Med Suisse. 2014 Dec 3;10(453):2306-10.

PubMed Abstract
PMID: 25626246

Article in French. Prostate Cancer Section


Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.